BC Cardiovascular Community at the Canadian Cardiovascular Congress

Rising Stars – Dr. Jaqueline Saw

JSaw

Dr. Jacqueline Saw is a Clinical Associate Professor in the Division of Cardiology at the University of British Columbia, Program Director for VGH Interventional Cardiology Fellowship Program and Head for VGH Cardiology Clinical Trials Research. She received her MD from the University of Ottawa. Her clinical expertise is in management of SCAD (spontaneous artery dissection), FMD (fibromuscular dysplasia) and left atrial appendage closure. Current research interests include spontaneous coronary artery dissection (SCAD), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral intervention, left atrial appendage closure, and non-atherosclerotic coronary artery disease [including SCAD and coronary FMD in women]. She is the principal investigator of the Canadian SCAD Study, PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies.

Lay summary of program/project:

Her interest in SCAD started in April 2011 when she diagnosed 3 SCAD cases over a 2-week period at VGH with the aid of optical coherence tomography. She described the first case series of patients with SCAD and concomitant FMD. Since then, she has accumulated a large series of patients with SCAD, initially predominantly from VGH, and subsequently through educating and raising awareness of this condition in BC, SCAD patients are also increasingly being referred from surrounding BC hospitals and cardiologists.

Medical summary of program/project:

Canadian SCAD: This observational study is designed to ascertain the natural history according to pre disposing arteriopathies and treatment strategy on long-term cardiovascular outcomes. The design of this study will secondarily improve the diagnosis of SCAD on coronary angiography by participating clinicians and provide guidance on investigating predisposing conditions.